High cost of nuclear medicine weighed

Dec 26, 2007

U.S. advances in the use of nuclear accelerators to fight cancer are being tempered by concerns about the high cost of such equipment with uncertain benefits.

Scientists say the particle accelerators target cancer cells more accurately than X-rays, The New York Times reported Tuesday. But some experts say the rush to newer, more expensive technology -- which can cost more than $100 million a pop -- is what is pushing the high cost of healthcare in the United States, the Times said.

"I'm fascinated and horrified by the way it's developing," said Anthony L. Zietman, a radiation oncologist at Harvard and Massachusetts General Hospital, which operates a proton center. "This is the dark side of American medicine."

Proponents say the accelerators will ultimately mean better treatment for cancer patients. More than 800,000 Americans undergo radiation therapy each year.

"Every X-ray beam I use puts most of the dose where I don't want it," said Dr. Jerry D. Slater, head of radiation medicine at Loma Linda University Medical Center in California.

But opponents say the newest form of X-rays diminish any advantages from proton therapy.

"There are no solid clinical data that protons are better," said Dr. Theodore S. Lawrence, chairman of radiation oncology at the University of Michigan.

Copyright 2007 by United Press International

Explore further: Invasive procedures down with noninvasive prenatal testing

add to favorites email to friend print save as pdf

Related Stories

Taking great ideas from the lab to the fab

Jul 31, 2014

A "valley of death" is well-known to entrepreneurs—the lull between government funding for research and industry support for prototypes and products. To confront this problem, in 2013 the National Science ...

Recommended for you

New approach to particle therapy dosimetry

16 hours ago

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.